THERAPEUTIC COMPOUNDS AS INHIBITORS OF THE OREXIN-1 RECEPTOR
The present invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their us...
Saved in:
| Main Authors | , , , |
|---|---|
| Format | Patent |
| Language | English French German |
| Published |
18.11.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity. |
|---|---|
| AbstractList | The present invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity. |
| Author | WATSON, Martin John NOWAK, Thorsten MARTIN, Barrie Phillip BLANEY, Emma Louise |
| Author_xml | – fullname: MARTIN, Barrie Phillip – fullname: NOWAK, Thorsten – fullname: BLANEY, Emma Louise – fullname: WATSON, Martin John |
| BookMark | eNrjYmDJy89L5WSwCfFwDXIMcA0N8XRWcPb3DfAP9XMJVnAMVvD08_B08gzxDwpW8HdTACpT8A9yjfD00zVUCHJ1dg0AyvAwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXAGNDC0sDE2MnQ2MilAAAyD8q9Q |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | THERAPEUTISCHE VERBINDUNGEN ALS INHIBITOREN DER OREXIN-1-REZEPTOR COMPOSÉS THÉRAPEUTIQUES UTILISABLES EN TANT QU'INHIBITEURS DU RÉCEPTEUR DE L'OREXINE-1 |
| ExternalDocumentID | EP3189043B1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EP3189043B13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:45:22 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French German |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EP3189043B13 |
| Notes | Application Number: EP20150762678 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201118&DB=EPODOC&CC=EP&NR=3189043B1 |
| ParticipantIDs | epo_espacenet_EP3189043B1 |
| PublicationCentury | 2000 |
| PublicationDate | 20201118 |
| PublicationDateYYYYMMDD | 2020-11-18 |
| PublicationDate_xml | – month: 11 year: 2020 text: 20201118 day: 18 |
| PublicationDecade | 2020 |
| PublicationYear | 2020 |
| RelatedCompanies | C4x Discovery Limited |
| RelatedCompanies_xml | – name: C4x Discovery Limited |
| Score | 3.3011298 |
| Snippet | The present invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds have the structural formula I defined herein. The... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | THERAPEUTIC COMPOUNDS AS INHIBITORS OF THE OREXIN-1 RECEPTOR |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201118&DB=EPODOC&locale=&CC=EP&NR=3189043B1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig_St2K7dlsLDlnTlFZYU7pO9jaWroG9dMNV_Pe9lG76om8hF47LkV8ul-TuAJ6EUwhpDk09l4al26vc1Z1ihV6KNKUwxcDpSRU7PIkH4cx-m_fnLVjvY2HqPKFfdXJERFSOeK_q_Xr7c4nl138rd89ijV2b1yAb-VrjHStrhnD2vRFLuM-pRim2tDgd4dJ1Ddvy0FE6wlP0UIGBvXsqKGX726IE53CcILOyuoBWUXbglO4Lr3XgZNK8d2Ozgd7uEl6ykKXjhM2yiBLKJwmfxf6UjKckisPIizKeTgkPCA4jPGXzKNZNkjLKEqRcAQlYRkMdxVgcprxgyUFg6xra5aYsboAUPWMpl2izbdexc9dwhVipGrZSDl0xsPIudP9kc_sP7Q7OlO5UiJ3p3EO7-vgsHtDWVuKx1tI3Ge1-VQ |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL8s0zjfdGqcn30weyPCwA0SFzNKCeighDGzt2UFmuyFLQ7jv-9BtumLvjW95nK99Nfrtb07gAdh5kJqA01JpaorRpZaipln6KVITQpN9M2erGKHg7DvTY3X2dOsActdLEydJ_SrTo6IiEoR72W9X69_LrGc-m_l5lEssWv14iZDp7v1jitrhnB27CGLuMNpl1JsdcN4iEvXUg3dRkfpAE_YgwoM7N2uglLWvy2KewKHETIrylNo5EUbWnRXeK0NR8H2vRubW-htzuA58Vg8itg08SmhPIj4NHQmZDQhfuj5tp_weEK4S3AY4TGb-aGikZhRFiHlHIjLEuopKMZ8P-U5i_YC6xfQLFZFfgkk76kLuUCbbVimkVqqJURW1bCVcmCJvp52oPMnm6t_aPfQ8pJgPB_74ds1HFd6rMLtNPMGmuXHZ36LdrcUd7XGvgEyM4FI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=THERAPEUTIC+COMPOUNDS+AS+INHIBITORS+OF+THE+OREXIN-1+RECEPTOR&rft.inventor=MARTIN%2C+Barrie+Phillip&rft.inventor=NOWAK%2C+Thorsten&rft.inventor=BLANEY%2C+Emma+Louise&rft.inventor=WATSON%2C+Martin+John&rft.date=2020-11-18&rft.externalDBID=B1&rft.externalDocID=EP3189043B1 |